258 related articles for article (PubMed ID: 24991323)
1. Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.
Greenapple R
Am Health Drug Benefits; 2012 Jul; 5(4):242-53. PubMed ID: 24991323
[TBL] [Abstract][Full Text] [Related]
2. Payer perceptions of the use of real-world evidence in oncology-based decision making.
Brixner D; Biskupiak J; Oderda G; Burgoyne D; Malone DC; Arondekar B; Niyazov A
J Manag Care Spec Pharm; 2021 Aug; 27(8):1096-1105. PubMed ID: 34337998
[No Abstract] [Full Text] [Related]
3. Rapid expansion of new oncology care delivery payment models: results from a payer survey.
Greenapple R
Am Health Drug Benefits; 2013 Jul; 6(5):249-56. PubMed ID: 24991361
[TBL] [Abstract][Full Text] [Related]
4. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
Nemlekar P; Shepherd M; Lawson K; Rush S
J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
[TBL] [Abstract][Full Text] [Related]
5. Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.
Royce TJ; Schenkel C; Kirkwood K; Levit L; Levit K; Kircher S
JCO Oncol Pract; 2020 May; 16(5):276-284. PubMed ID: 32310720
[TBL] [Abstract][Full Text] [Related]
6. Improving Oncology Quality Measurement in Accountable Care: Filling Gaps with Cross-Cutting Measures.
Valuck T; Blaisdell D; Dugan DP; Westrich K; Dubois RW; Miller RS; McClellan M
J Manag Care Spec Pharm; 2017 Feb; 23(2):174-181. PubMed ID: 28125364
[TBL] [Abstract][Full Text] [Related]
7. Payer perceptions on the use of economic models in oncology decision making.
Biskupiak J; Oderda G; Brixner D; Burgoyne D; Arondekar B; Niyazov A
J Manag Care Spec Pharm; 2021 Nov; 27(11):1560-1567. PubMed ID: 34714111
[No Abstract] [Full Text] [Related]
8. Trends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers.
Greenapple R
Am Health Drug Benefits; 2012 Mar; 5(2):83-92. PubMed ID: 24991313
[TBL] [Abstract][Full Text] [Related]
9. Managing drug costs: the perception of managed care pharmacy directors.
Litton LM; Sisk FA; Akins ME
Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples.
Brogan AP; DeMuro C; Barrett AM; D'Alessio D; Bal V; Hogue SL
J Manag Care Spec Pharm; 2017 Feb; 23(2):125-134. PubMed ID: 28125369
[TBL] [Abstract][Full Text] [Related]
12. Payer perceptions on the use of patient-reported outcomes in oncology decision making.
Oderda G; Brixner D; Biskupiak J; Burgoyne D; Arondekar B; Deal LS; Quek RG; Niyazov A
J Manag Care Spec Pharm; 2022 Feb; 28(2):188-195. PubMed ID: 34806908
[No Abstract] [Full Text] [Related]
13. AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and Reimbursement.
J Manag Care Spec Pharm; 2020 Oct; 26(10):1206-1213. PubMed ID: 32780612
[TBL] [Abstract][Full Text] [Related]
14. Oncologist Support for Consolidated Payments for Cancer Care Management in the United States.
Narayanan S; Hautamaki E
Am Health Drug Benefits; 2016 Jul; 9(5):280-9. PubMed ID: 27625745
[TBL] [Abstract][Full Text] [Related]
15. Impact of multi-tiered pharmacy benefits on attitudes of plan members with chronic disease states.
Nair KV; Ganther JM; Valuck RJ; McCollum MM; Lewis SJ
J Manag Care Pharm; 2002; 8(6):477-91. PubMed ID: 14613381
[TBL] [Abstract][Full Text] [Related]
16. The evolution of payer management of oncology drugs in the United States between 2017 and 2022.
Runyan A; Yi J; Honcz J
J Manag Care Spec Pharm; 2023 Oct; 29(10):1138-1149. PubMed ID: 37695273
[No Abstract] [Full Text] [Related]
17. Pharmacy students' views of managed care pharmacy and PBMS: should there be more exposure to managed care in the pharmacy curriculum?
Pittenger AL; Starner CI; Thompson K; Gleason PP
J Manag Care Pharm; 2010 Jun; 16(5):346-54. PubMed ID: 20518587
[TBL] [Abstract][Full Text] [Related]
18. Managed care market perspectives on the over-the-counter availability of statins.
Richards MK; Blumenfield S; Lyon RA
J Manag Care Pharm; 2004; 10(6):543-50. PubMed ID: 15548127
[TBL] [Abstract][Full Text] [Related]
19. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
[TBL] [Abstract][Full Text] [Related]
20. Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers.
Lopata E; Terrone C; Gopalan A; Ladikos N; Richardson T
J Manag Care Spec Pharm; 2021 Jun; 27(6):706-713. PubMed ID: 33586514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
